Multifocal papillary thyroid carcinoma - A consensus report of the European Society of Endocrine Surgeons (ESES)

Langenbeck's Archives of Surgery

Volumn 399, Issue 2, 2014, Pages 141-154

  Iacobone, Maurizio ^a   Jansson, Svante ^b   Barczyński, Marcin ^c   Goretzki, Peter ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d Department of Visceral and Endocrine Surgery Lukaskrankenhaus Neuss ^*  (Germany)

Author keywords

Multifocality; Papillary thyroid carcinoma; Thyroidectomy

Indexed keywords

ADULT; CANCER LOCALIZATION; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CONSENSUS; ECHOGRAPHY; EUROPE; EVIDENCE BASED MEDICINE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIFOCAL PAPILLARY THYROID CARCINOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THYROID METASTASIS; THYROID PAPILLARY CARCINOMA; TREATMENT PLANNING; TUMOR VOLUME;

ADENOCARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; CHERNOBYL NUCLEAR ACCIDENT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EUROPE; NECK DISSECTION; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84896037091     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-013-1145-7     Document Type: Review

References (111)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83:2638-2648 (Pubitemid 29019586)
2. Leenhardt L, Bernier MO, Boin-Pineau MH et al (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150:133-139 (Pubitemid 38312805)
3. Kuhn E, Teller L, Piana S et al (2012) Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature. Endocr Pathol 23:101-107
4. CarcangiuML, ZampiG, PupiAet al (1985) Papillary carcinoma of the thyroid-A clinicopathologic study of 247 cases treated at the University of Florence, Italy. Cancer 55:805-828 (Pubitemid 15173519)
5. Katoh R, Sasaki J, Kurihara H et al (1992) Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: a clinicopathologic study of 105 consecutive patients. Cancer 70:1585-1590
6. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
7. Mazeh H, Samet Y, Hochstein D et al (2011) Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy. Am J Surg 201:770-775
8. Bogdanova TI, Zurnadzhy LY, Greenebaum E et al (2006) A cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident. Cancer 107:2559-2566
9. Ron E, Lubin JH, Shore RE et al (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
10. Nikiforov YE (2006) Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocr Pathol 17:307-317
11. Fridman MV, Savva NN, Krasko OV et al (2012) Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid 22:1016-1024
12. Lee KJ, Cho YJ, Kim JG et al (2013) How many contralateral papillary thyroid carcinomas can be missed? World J Surg 4:780-785
13. Kim HJ, Sohn SY, Jang HW et al (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37:376-384
14. Schonberger J, Marienhagen J, Agha A et al (2007) Papillary microcarcinoma and papillary cancer of the thyroid < or = 1 cm: modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46:115-120 (Pubitemid 47356533)
15. Pasieka JL, Thompson NW, McLeod MK et al (1992) The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg 16:711-716
16. Agency for Health Care Policy and Research (1992) Acute pain management: operative or medical procedures and trauma. Clinical practice guideline number 1. AHCPR, Rockville, p 107.
17. Agency for Health Care Policy and Research (1994) Management of cancer pain: adults. Clinical practice guideline number 9. AHCPR, Rockville.
18. Iida F, Yonekura M, Miyakawa M (1969) Study of intraglandular dissemination of thyroid cancer. Cancer 24:764-771
19. Shattuck TM, Westra WH, Ladenson et al (2005) Independent clonal origins of distinct tumor foci in multifocal
20. McCarthy RP, Wang M, Jones TD, Strate RW, Cheng L (2006) Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. Clin Cancer Res 12:2414-2418
21. Wang W, Wang H, Teng X et al (2010) Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol 41:1299-1309
22. Jovanovic L, Delahunt B, McIver B et al (2008) Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intraglandular spread of the initial neoplastic clone. J Pathol 215:145-154 (Pubitemid 351786033)
23. Sugg SL, Ezzat S, Rosen IB et al (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83:4116-4122 (Pubitemid 28513605)
24. Moniz S, Catarino AL, Marques AR et al (2002) Clonal origin of nonmedullary thyroid tumors assessed by nonrandom X-chromosome inactivation. Eur J Endocrinol 146:27-33 (Pubitemid 34126415)
25. Park SY, Park YJ, Lee YJ et al (2006) Analysis of differential BRAFV600E mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer 107:1831-1838 (Pubitemid 44582952)
26. Lin X, Finkelstein SD, Zhu B et al (2008) Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol 41:195-203
27. Wang W, Zhao W, Whang H et al (2012) Poorer prognosis and higher prevalence of BRAFV600Emutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol 19:31-36
28. De Vries JH (2005)Multifocal papillary thyroid carcinoma. N Engl J Med 353:1067
29. Lin JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16:2609-2616
30. Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary thyroid cancer. J Clin Endocrinol Metab 86:1447-1463 (Pubitemid 32374886)
31. Kirath PÖ, Volkan-Salanci B, Günay EC et al (2011) Thyroid cancer in pediatric age group: an institutional experience and review of the literature. J Pediatr Hematol Oncol 35:93-97
32. Enomoto Y, Enomoto K, Uchino S et al (2012) Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg 36:1241-1246
33. Welch Dinauer CA, Tuttle RM, Robie DK et al (1997) Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents, and young adults. Clin Endocrinol 49:619-628 (Pubitemid 28529761)
34. Pacini F, Elisei R, Capezzone M et al (2001) Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 11:877-881 (Pubitemid 32847946)
35. Moses W, Weng J, Khanafshar E et al (2010) Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res 160:179-183
36. Yamamoto Y, Maeda T, Izumi K et al (1990) Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 65:1173-1179 (Pubitemid 20072054)
37. Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538 (Pubitemid 15035581)
38. Robinson DW, Orr TG (1955) Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 70:923-928
39. Nosé V (2011) Familial thyroid cancer: a review. Mod Pathol 24:19-33
40. Uchino S, Noguchi S, Kawamoto H et al (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and high recurrence rate in a large population. World J Surg 26:897-902 (Pubitemid 36920283)
41. Capezzone M, Marchisotta S, Cantara S et al (2008) Familial nonmedullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr-Relat Cancer 15:1075-1081
42. McDonald TJ, Driedger AA, Garcia BM et al (2011) Familial papillary thyroid carcinoma: a retrospective analysis. J Oncol 10:1-8
43. Musholt TJ, Musholt PB, Petrich T et al (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24:1409-1417
44. Loh KC (1997) Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113
45. Alsanea O, Wada N, Ain K et al (2000) Is familial nonmedullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043-1050
46. Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-933 (Pubitemid 46716780)
47. Hildebrand A, Varhaug JE, Brauckhoff M et al (2010) Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. Langenbeck's Arch Surg 395:851-858
48. Pitt SC, Sippel RS, Chen H (2009) Contralateral papillary thyroid cancer: does size matter? Am J Surg 197:342-347
49. Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1-33
50. Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
51. Baudin E, Travagli JP, Ropers J et al (1998) Microcarcinoma of the thyroid gland. Cancer 83:553-559
52. Davies L, Welsh HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
53. Piersanti M, Ezzat S, Asa S (2003) Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 14:183-191 (Pubitemid 37346700)
54. Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-988
55. Ricci JA, Alfonso AE (2012) Multifocal micropapillary thyroid cancer: a new indication for total thyroidectomy? Am Surg 78:1211-1214
56. He Q, Zhuang D, Zheng L et al (2012) The surgical management of papillary thyroid microcarcinoma: a 162-month single-center experience of 273 cases. Am Surg 78:1215-1218
57. Pellegriti G, Scollo C, Lumera G et al (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720 (Pubitemid 39071462)
58. Lombardi CP, Bellantone R, De Crea C et al (2010) Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg 34:1214-1221
59. Vasileiadis I, Karakostas E, Charitoudis G et al (2012) Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. Eur J Clin Investig 42:657-664
60. Zhou YL, Gao EL, Zhang W et al (2012) Factors predictive of papillary thyroid microcarcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol 10:67-72
61. Zhang L, Wei W-J, Ji Q-H et al (2012) Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1,066 patients. J Clin Endocrinol Metab 97:1250-1257
62. Ross DS, Litofsky D, Ain KB et al (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043-1048
63. Neuhold N, Schultheis A, Hermann M et al (2011) Incidental papillary microcarcinoma of the thyroid-further evidence of very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 18:3430-3436
64. Zhao Q, Ming J, Liu C et al (2013) Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol 20:746-752
65. Chow SM, Law SC, Chan JK et al (2003) Papillarymicrocarcinoma of the thyroid - prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40 (Pubitemid 36741122)
66. Schlumberger M, Travagli JP, Lemerle J et al (1987) Differentiated thyroid carcinoma in childhood. Experience at Institut Gustave-Roussy, Villejuif. Acta Otorhinolaryngol Belg 41:804-808
67. Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin EndocrinolMetab 90: 5723-5729 (Pubitemid 41415482)
68. Schindler AM, van Melle G, Evequoz B et al (1991) Prognostic factors in papillary carcinoma of the thyroid. Cancer 68:324-330
69. Sciuto R, Romano L, Rea S et al (2009) Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1,503 patients treated at a single institution. Ann Oncol 20:1728-1735
70. Zheng X-Q, Xia T, Lin L et al (2012) BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China. World J Surg Oncol 10:104-110
71. Grigsby PW, Reddy RM, Moley JF et al (2006) Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 140:1043-1047
72. Frates MC, Benson CB, Charboneau JWet al (2005) Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement1. Radiology 237:794-800 (Pubitemid 41636365)
73. Sakorafas GH, Giotakis J, Stafyla V (2005) Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31:423-438 (Pubitemid 41536166)
74. Choi JS, Chung WY, Kwak JY et al (2011) Staging of papillary thyroid carcinoma with ultrasonography: performance in a large series. Ann Surg Oncol 18:3572-3578
75. Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289 (Pubitemid 23046388)
76. Bramley MD, Harrison BJ (1996) Papillary microcarcinoma of the thyroid gland. Br J Surg 83:1674-1683 (Pubitemid 26421859)
77. Salvatore G, Giannini R, Faviana P et al (2004) Analysis of BRAF point mutation and RET/PTC rearrangements refines the fineneedle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89:5175-5180 (Pubitemid 39391466)
78. Xing M, Tufano RP, Tufaro AP et al (2004) Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin EndocrinolMetab 89:2867-2872 (Pubitemid 38766378)
79. SapioRM, Posca D, Raggioli A et al (2007)Detection of RET/PTC, TRK, and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf) 66:678-683 (Pubitemid 46699541)
80. Clark OH (1982) Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196:361-370
81. Kebebew E, Clark OH (2000) Differentiated thyroid cancer: "complete" rational approach. World J Surg 24:942-951 (Pubitemid 30461215)
82. ATA Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR et al (2009) American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167-1214
83. Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153-1158
84. Lundgren CI, Hall P, Dickman PWet al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524-531 (Pubitemid 43157614)
85. Tisell LE, Nilsson B, Mölne J et al (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20:854-859 (Pubitemid 26281914)
86. So YK, Son YI, Hong SD et al (2010) Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery 148:526-531
87. Lim YC, Choi EC, Yoon YH (2009) Central lymph nodemetastases in unilateral papillary thyroid microcarcinoma. Br J Surg 96:253-257
88. Shao Y, Cai XJ, Gao L (2009) Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma: clinical analysis of 117 cases. Zhonghua Yi Xue Za Zhi 89:403-405
89. Xu Y, Wang J (2007) Analysis of lymph node metastasis factors in papillary thyroid microcarcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21:679-682
90. Wang Y, Ji QH, Huang CP et al (2008) Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma. Zhonghua Yan Ke Za Zhi 46:1899-1901
91. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407 (Pubitemid 38176456)
92. Ito Y, Miyauchi A (2008) Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg 32:729-739
93. Lee SH, Lee SS, Jin SM et al (2008) Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Laryngoscope 118:659-662
94. Barbaro D, Simi U, Meucci G et al (2005) Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and nonincidental cancers - are they different diseases? Clin Endocrinol (Oxf) 63:577-581 (Pubitemid 41626754)
95. Page C, Biet A, Boute P et al (2009) "Aggressive papillary" thyroid microcarcinoma. Eur Arch Otorhinolaryngol 266:1959-1963
96. Barczynski M, Konturek A, Stopa M et al (2013) Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg 100:410-418
97. Kim ES, Kim TY, Koh JM et al (2004) Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) 61:145-148
98. Kupferman ME, Mandel SJ, DiDonato L et al (2002) Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope 112:1209-1212 (Pubitemid 34747217)
99. Dietlein M, Luyken WA, Schicha H et al (2005) Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough? Nucl Med Commun 26:3-8 (Pubitemid 40189618)
100. Sawka AM, Brierley JD, Tsang RW (2008) An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin N Am 37:457-480 (Pubitemid 351711675)
101. Edge SB, Byrd DR, Compton CC et al (2010) AJCC Cancer Staging Handbook: AJCC Cancer Staging Manual, 7th ed. Springer, New York
102. Rosario PW, Xavier AC, Calsolari MR (2011) Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and 131-I activity in patients with thyroid cancer and low risk of recurrence. Thyroid 21:49-53
103. Nascimento C, Borget I, Al Ghuzlan A et al (2011) Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocr-Relat Cancer 18:R29-R40
104. Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2,444 consecutively treated patients. World J Surg 26:879-885 (Pubitemid 36920280)
105. Buffet C, Golmard JL, Hoang C et al (2012) Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma. Eur J Endocrinol 167:267-275
106. Ardito G, Revelli L, Giustozzi E et al (2013) Aggressive papillary thyroidmicrocarcinoma: prognostic factors and therapeutic strategy. Clin Nucl Med 38:25-28
107. Gemsenjäger EW, Heitz PU, Schweizer I (2005) Multifocal papillary thyroid carcinoma. N Engl J Med 353:1067
108. Meas T, Vercellino L, Faugeron I et al (2013) The 2009 Revised American Thyroid Association Guidelines for Thyroid Cancer: multifocality in T1 tumors in question, for or against a more minimalist approach? Thyroid 23:1042-1043
109. Cailleux AF, Baudin E, Travagli JP et al (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 85:175-178 (Pubitemid 32268810)
110. Bachelot A, Cailleux AF, KlainMet al (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707-711 (Pubitemid 34913243)
111. Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707-716